Medications for Neuroendocrine Tumors
9 results
Afinitor (everolimus)
(everolimus)Novartis Pharmaceuticals Corporation
Usage: AFINITOR is indicated for postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer, progressive neuroendocrine tumors, advanced renal cell carcinoma, and various Tuberous Sclerosis Complex-related conditions, including renal angiomyolipoma, subependymal giant cell astrocytoma, and partial-onset seizures.
Cabometyx (cabozantinib)
(cabozantinib)Exelixis, Inc.
Usage: CABOMETYX is indicated for advanced renal cell carcinoma (RCC), in combination with nivolumab for first-line treatment; hepatocellular carcinoma (HCC) after sorafenib; differentiated thyroid cancer (DTC) in patients aged 12 and older with prior VEGFR therapy failure; and well-differentiated neuroendocrine tumors (pNET and epNET) in patients aged 12 and older.
Detectnet (copper cu 64 dotatate)
(copper Cu 64 Dotatate)CURIUM US LLC
Usage: Detectnet is indicated for use with positron emission tomography (PET) to localize somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients.
Everolimus (everolimus)
(Everolimus)Natco Pharma Limited
Usage: Everolimus is indicated for postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer, and for adult patients with progressive neuroendocrine tumors, renal cell carcinoma post sunitinib/sorafenib failure, renal angiomyolipoma in tuberous sclerosis, and subependymal giant cell astrocytoma in TSC.
Ga-68-dotatoc (edotreotide gallium ga-68)
(EDOTREOTIDE GALLIUM GA-68)UIHC – P E T Imaging Center
Usage: Ga 68 DOTATOC Injection is indicated for use with PET to localize somatostatin receptor positive neuroendocrine tumors (NETs) in both adult and pediatric patients.
I 123 mibg (i 123 mibg)
(i 123 MIBG)AnazaoHealth Corporation
Usage: Iobenguane (I-123 MIBG) is indicated for diagnostic imaging of adrenomedullary disorders, neuroendocrine tumors, pheochromocytomas, paragangliomas, neuroblastomas, carcinoid tumors, and medullary thyroid carcinoma. It assists in the evaluation, localization, and confirmation of these conditions, particularly when other tests yield unclear results.
Kit for the preparation of indium in 111 pentetreotide (indium in-111 pentetreotide)
(Indium In-111 Pentetreotide)Sun Pharmaceutical Industries, Inc.
Usage: Indium In-111 pentetreotide injection is used for scintigraphic localization of primary and metastatic neuroendocrine tumors that express somatostatin receptors.
Netspot (68ga-dotatate)
(68Ga-DOTATATE)Advanced Accelerator Applications USA, Inc
Usage: NETSPOT, after gallium-68 radiolabeling, is indicated for use with positron emission tomography (PET) to localize somatostatin receptor-positive neuroendocrine tumors (NETs) in both adult and pediatric patients.
Octreoscan (indium in -111 pentetreotide)
(Indium In -111 Pentetreotide)Curium US LLC
Usage: Octreoscan is used for scintigraphic localization of primary and metastatic neuroendocrine tumors that express somatostatin receptors, following radiolabeling.